Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project.
Hurle R, Lazzeri M, Vanni E, Lughezzani G, Buffi N, Casale P, Saita A, Morenghi E, Forni G, Cardone P, Lista G, Colombo P, Peschechera R, Pasini L, Zandegiacomo S, Benetti A, Maffei D, Vavassori I, Guazzoni G. Hurle R, et al. Among authors: maffei d. J Urol. 2018 Feb;199(2):401-406. doi: 10.1016/j.juro.2017.08.091. Epub 2017 Aug 26. J Urol. 2018. PMID: 28847481
68Ga-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study.
Lopci E, Saita A, Lazzeri M, Lughezzani G, Colombo P, Buffi NM, Hurle R, Marzo K, Peschechera R, Benetti A, Zandegiacomo S, Pasini L, Lista G, Cardone P, Castello A, Maffei D, Balzarini L, Chiti A, Guazzoni G, Casale P. Lopci E, et al. Among authors: maffei d. J Urol. 2018 Jul;200(1):95-103. doi: 10.1016/j.juro.2018.01.079. Epub 2018 Feb 1. J Urol. 2018. PMID: 29409824
Long-term outcomes of high-grade T1 bladder cancer treated with intravesical bacillus Calmette-Guérin: experience of a single center.
Hurle R, Buffi N, Lista G, Cardone P, Forni G, Maffei D, Peschechera R, Zandegiacomo S, Pasini L, Benetti A, Colombo P, Lazzeri M, Casale P, Guazzoni G, Lughezzani G. Hurle R, et al. Among authors: maffei d. Minerva Urol Nefrol. 2018 Oct;70(5):501-508. doi: 10.23736/S0393-2249.18.03042-4. Epub 2018 Jul 3. Minerva Urol Nefrol. 2018. PMID: 29968999 Free article.
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study.
Casale P, Saita A, Lazzeri M, Lughezzani G, Hurle R, Fasulo V, Mondellini GM, Paciotti M, Domanico L, Lista G, Maffei D, Monari M, Motta L, Bini V, Ceriotti F, Guazzoni G, Buffi NM. Casale P, et al. Among authors: maffei d. Minerva Urol Nefrol. 2019 Jun;71(3):273-279. doi: 10.23736/S0393-2249.19.03279-X. Epub 2019 Jan 28. Minerva Urol Nefrol. 2019. PMID: 30700081 Free article.
Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project.
Hurle R, Colombo P, Lazzeri M, Lughezzani G, Buffi NM, Saita A, Elefante GM, Morenghi E, Forni G, Cardone P, Lista G, Maffei D, Guazzoni G, Casale P. Hurle R, et al. Among authors: maffei d. Eur Urol Oncol. 2018 Oct;1(5):437-442. doi: 10.1016/j.euo.2018.05.006. Epub 2018 Jun 5. Eur Urol Oncol. 2018. PMID: 31158085
Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer.
Lughezzani G, Saita A, Lazzeri M, Paciotti M, Maffei D, Lista G, Hurle R, Buffi NM, Guazzoni G, Casale P. Lughezzani G, et al. Among authors: maffei d. Eur Urol Oncol. 2019 May;2(3):329-332. doi: 10.1016/j.euo.2018.10.001. Epub 2018 Oct 25. Eur Urol Oncol. 2019. PMID: 31200848
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project.
Hurle R, Casale P, Saita A, Colombo P, Elefante GM, Lughezzani G, Fasulo V, Paciotti M, Domanico L, Bevilacqua G, Maffei D, Diana P, Frego N, Sandri MT, Maura F, Morenghi E, Buffi NM, Guazzoni G, Lazzeri M. Hurle R, et al. Among authors: maffei d. World J Urol. 2020 Sep;38(9):2215-2220. doi: 10.1007/s00345-019-03002-3. Epub 2019 Nov 5. World J Urol. 2020. PMID: 31691083
Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis.
Klotz L, Lughezzani G, Maffei D, Sánchez A, Pereira JG, Staerman F, Cash H, Luger F, Lopez L, Sanchez-Salas R, Abouassaly R, Shore ND, Eure G, Paciotti M, Astobieta A, Wiemer L, Hofbauer S, Heckmann R, Gusenleitner A, Kaar J, Mayr C, Loidl W, Rouffilange J, Gaston R, Cathelineau X, Klein E. Klotz L, et al. Among authors: maffei d. Can Urol Assoc J. 2021 Jan;15(1):E11-E16. doi: 10.5489/cuaj.6712. Can Urol Assoc J. 2021. PMID: 32701437 Free PMC article.
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study.
Lughezzani G, Maffei D, Saita A, Paciotti M, Diana P, Buffi NM, Colombo P, Elefante GM, Hurle R, Lazzeri M, Guazzoni G, Casale P. Lughezzani G, et al. Among authors: maffei d. Eur Urol Focus. 2021 Sep;7(5):1019-1026. doi: 10.1016/j.euf.2020.09.013. Epub 2020 Oct 15. Eur Urol Focus. 2021. PMID: 33069624
78 results